Population Pharmacokinetics of Magnesium Sulfate in Preeclampsia and Associated Factors
Abstract Background and Objective The pharmacokinetic basis of magnesium sulphate (MgSO4) dosing regimens for preeclampsia (PE) prophylaxis and treatment is not clearly established. The aim of study is to develop a population pharmacokinetic (PK) model of MgSO4 in PE, and to determine key covariates...
Main Authors: | Tatiana Xavier da Costa, Francine Johansson Azeredo, Marcela Abbott Galvão Ururahy, Miguel Adelino da Silva Filho, Rand Randall Martins, Antonio Gouveia Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-07-01
|
Series: | Drugs in R&D |
Online Access: | https://doi.org/10.1007/s40268-020-00315-2 |
Similar Items
-
Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsiaAJOG Global Reports at a Glance
by: Kathleen Brookfield, MD, PhD, MPH, et al.
Published: (2021-11-01) -
Shortened Postpartum Magnesium Sulfate Treatment for Severe Preeclampsia
by: Jiraphol Kumpalum, et al.
Published: (2010-06-01) -
The pharmacokinetics and pharmacodynamics of intravenous magnesium sulfate in horses
by: Schumacher, Stephen A.
Published: (2019) -
A Comparison between Intravenous Magnesium Sulfate and Oral Magnesium Chloride in Mild Preeclampsia
by: A Ghahiri, et al.
Published: (2005-01-01) -
Metabolomic Profiles of Placenta in Preeclampsia: Antioxidant Effect of Magnesium Sulfate on Trophoblasts in Early-Onset Preeclampsia
by: Kawasaki, Kaoru
Published: (2019)